Choreo LLC purchased a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 26,850 shares of the company’s stock, valued at approximately $134,000.
A number of other hedge funds have also modified their holdings of the business. Arizona State Retirement System grew its holdings in shares of LifeStance Health Group by 22.9% during the 2nd quarter. Arizona State Retirement System now owns 31,972 shares of the company’s stock worth $157,000 after purchasing an additional 5,959 shares during the period. Victory Capital Management Inc. grew its holdings in shares of LifeStance Health Group by 27.0% during the 2nd quarter. Victory Capital Management Inc. now owns 14,407 shares of the company’s stock worth $71,000 after purchasing an additional 3,063 shares during the period. TD Asset Management Inc purchased a new position in shares of LifeStance Health Group during the 2nd quarter worth $623,000. Rhumbline Advisers grew its holdings in shares of LifeStance Health Group by 17.6% during the 2nd quarter. Rhumbline Advisers now owns 182,131 shares of the company’s stock worth $894,000 after purchasing an additional 27,280 shares during the period. Finally, CIBC Asset Management Inc purchased a new position in shares of LifeStance Health Group during the 2nd quarter worth $53,000. 85.50% of the stock is currently owned by hedge funds and other institutional investors.
LifeStance Health Group Price Performance
LFST opened at $6.81 on Friday. The stock’s 50-day moving average price is $6.03 and its 200 day moving average price is $6.04. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $9.20. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.20. The firm has a market cap of $2.60 billion, a price-to-earnings ratio of -14.19 and a beta of 1.22.
Analyst Ratings Changes
A number of equities analysts have recently weighed in on LFST shares. Barclays lowered their price target on LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating for the company in a report on Friday, August 9th. UBS Group decreased their target price on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a research note on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $8.25.
Check Out Our Latest Stock Analysis on LifeStance Health Group
Insider Buying and Selling at LifeStance Health Group
In other LifeStance Health Group news, insider Ann Varanakis sold 5,269 shares of the stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $6.28, for a total value of $33,089.32. Following the sale, the insider now owns 263,007 shares of the company’s stock, valued at approximately $1,651,683.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 6.60% of the stock is owned by corporate insiders.
LifeStance Health Group Profile
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Read More
- Five stocks we like better than LifeStance Health Group
- What is the Shanghai Stock Exchange Composite Index?
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- What Is WallStreetBets and What Stocks Are They Targeting?
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report).
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.